Erratum: Author correction to "The FAP α-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304]
- PMID: 36970198
- PMCID: PMC10031275
- DOI: 10.1016/j.apsb.2022.12.020
Erratum: Author correction to "The FAP α-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304]
Abstract
[This corrects the article DOI: 10.1016/j.apsb.2021.08.015.].
© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
Erratum for
-
The FAP α -activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway.Acta Pharm Sin B. 2022 Mar;12(3):1288-1304. doi: 10.1016/j.apsb.2021.08.015. Epub 2021 Aug 14. Acta Pharm Sin B. 2022. PMID: 35530139 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
